Finance entity
ipo is the sole category represented across all 1 tracked stories. Powerica is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.2 for that window.
Last mentioned: Mar 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
ipo is the sole category represented across all 1 tracked stories. Powerica is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Their average consequence score of 5 runs below the beat's 6.2 for that window. They are less corroborated than the beat average, carrying 2 original sources each against 2.4 for the same window. Sai Parenterals appears in 1 tracked Finance story from March 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 119 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Sai Parenterals. Shared-story counts are live from our verified record — not editorial picks.
Two significant initial public offerings, Powerica and Sai Parenterals, opened for subscription today, aiming to raise a combined ₹1,509 crore. Powerica leads the charge with a ₹1,100-crore issue focused on its wind power portfolio, while Sai Parenterals seeks ₹409 crore to bolster its pharmaceutical operations.
Sai Parenterals is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
